Erlotinib Unknown Status Phase 1 Trials for Esophageal Cancers / Precancerous Conditions Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00566800Erlotinib in Treating Patients With Barrett Esophagus